QT Vascular on why it chose to list in Singapore

QT Vascular, a company producing devices to treat diseased arteries in the heart and elsewhere, aims to develop new products and enhance its existing ones, and so is planning a listing on the Singapore Exchange (SGX) to fund its efforts.

The company, which operates out of California and Singapore, registered revenue of US$1,452,000 for FY2012; in FY2013 that ended Sept 30, revenue doubled to US$3,004,000.

Besides developing new products, the company plans to use the IPO proceeds for commercial expansion and for general working capital purposes.